Effects of Nicotinamide Riboside on Cognition and Sleep in Older Adults
Official title: The Benefits of Nicotinamide Riboside Upon Cognition and Sleep in Older Veterans
Run by State University of New York at Buffalo · NCT05500170 · Data updated 2026-11-12
This study is testing if taking nicotinamide riboside can improve thinking skills and sleep quality in older adults who have trouble with both.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years to 85 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | State University of New York at Buffalo Academic / other |
| Locations | 3 sites (Buffalo, New York and 2 other locations) |
| Status | Recruiting |
| Started | April 4, 2023 |
| Main results expected | August 30, 2027 |
| Study ends | August 30, 2027 |
| Registry record updated | September 24, 2026 |
| Trial ID | NCT05500170 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are older adults aged 65 years and above who experience poor sleep quality as indicated by a Pittsburgh Sleep Quality Index score greater than 5.
✕Probably not a fit
Patients with dementia or significant cognitive impairment, as indicated by a VA-SLUMS score below 20, are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the impact of nicotinamide riboside (NR) supplementation on cognitive function and sleep quality in older adults. It aims to determine whether increasing levels of nicotinamide adenine dinucleotide (NAD+) through NR can enhance brain-derived neurotrophic factor (BDNF) expression, which is crucial for cognitive health. Participants will be assessed using both subjective and objective measures of sleep and cognition, with a focus on those experiencing cognitive impairment and poor sleep quality. The study will also explore the relationship between NR supplementation and serum BDNF levels.
Why it matters
Potential benefit: If successful, this study could lead to new interventions that improve cognitive function and sleep quality in older adults, potentially delaying or preventing cognitive decline.
How similar studies have gone: While the specific approach of using nicotinamide riboside for cognitive and sleep improvement is novel, pre-clinical studies have shown promising results in enhancing cognition and sleep quality in animal models.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Sleep Quality. Pittsburgh Sleep Quality Index (PSQI) global score \>5 Exclusion Criteria: * Dementia. Veteran Affairs - St. Louis University Mental Status questionnaire (VA-SLUMS) score \<20
Where it's running
-
Buffalo Veteran Affairs Medical Center
Buffalo, New York, United States Recruiting -
State University of New York at Buffalo
Buffalo, New York, United States Not yet recruiting -
University at Buffalo State University of New York
Buffalo, New York, United States Not yet recruiting
Study contacts
- Study coordinator: Carleara Weiss, PhD, MS, RN
- Email: carleara@buffalo.edu
- Phone: 7168282006
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Physical activity habits and sleep/ breathing in obstructive sleep apnea
This study tests whether daily physical activity habits affect sleep quality and breathing measurements in people with obstructive sleep apnea who are on CPAP therapy.
-
Shoulder pain patients: see if breathing and chest exercises help pain and sleep
This study tests whether adding respiratory muscle strengthening and diaphragmatic breathing to shoulder rehab can reduce pain and improve sleep in adults with chronic shoulder pain.
-
Biomarkers That Signal Silent Strokes in High-Risk Cardiac Procedures
This study tests whether blood biomarkers NSE and NFLs can predict silent brain injuries and later cognitive problems in adults having high-risk transcatheter heart procedures.
-
Blood-based tests and digital cognitive checks to help triage dementia
This study tests whether adding blood biomarkers, APOE4 genetic info, and digital cognitive tests can help dementia diagnosis be faster in NHS Memory Clinics.
-
Cardiovascular and Cognitive Health Initiative
This study tests whether targeted cognitive and heart-health interventions can help improve thinking skills in adults with cardiovascular disease.
-
Synbiotic blend of LA-5 and agave inulin for mild cognitive impairment
This pilot crossover study tests whether a synbiotic containing Lactobacillus acidophilus LA-5 and agave inulin can help adults aged 60–75 with mild cognitive impairment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.